Corrine Savill, Chief Business Officer: Cullinan Therapeutics CGEM Sell · Filed 24/01/24

Trade details

Type: Insider sale
Amount: $49,582.5
Shares · price: 4,125 sh · $12.02 a share
Held after: 165,990 sh
Stock: Cullinan Therapeutics CGEM
Person: Corrine SavillChief Business Officer
Trade date: 24/01/22
Filed: 24/01/24
Days to filing: 2 days

Sold 2.4% of holdings

Share of holding sold: 2.4%

Cullinan Therapeutics trades, last 26 weeks

What else happened in Cullinan Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/23~24/02/21

Corrine Savill's recent trades

Corrine SavillChief Business Officer
Sell10b5-1 planCullinan Therapeutics
Sell10b5-1 plan
Cullinan Therapeutics
CGEM
$647.2K
40,000 sh
$647.2K
Filed 24/02/02
Traded 24/02/01
Corrine SavillChief Business Officer
Sell10b5-1 planCullinan Therapeutics
Sell10b5-1 plan
Cullinan Therapeutics
CGEM
$563.6K
40,000 sh
$563.6K
Filed 24/01/30
Traded 24/01/29
Corrine SavillChief Business Officer
Sell10b5-1 planCullinan Therapeutics
Sell10b5-1 plan
Cullinan Therapeutics
CGEM
$265.6K
21,316 sh
$265.6K
Filed 24/01/24
Traded 24/01/23
Corrine SavillChief Business Officer
Sell10b5-1 planCullinan Therapeutics
Sell10b5-1 plan
Cullinan Therapeutics
CGEM
$177.3K
14,559 sh
$177.3K
Filed 24/01/24
Traded 24/01/22